3rd Expanded Access Programmes Global Congress 2022 Americas
20th - 21st September 2022
Boston, MA, USA
Sponsors & Exhibitors
Early Access Care LLC
Early Access Care helps international clients with effective integrated solutions customized to their early access needs. Early Access Care specializes in pre-approval early access, managing the end-to-end (request intake to delivery at physician) process. Our goal is to Make Access More Accessible™.
We offer comprehensive high-touch services to manage requests globally.
Established over 50 years ago, Durbin is one of the world’s leading specialist Expanded Access Program providers, offering a bespoke distribution platform to provide patients with access to unlicensed and speciality medicines in over 160 countries. With offices and warehousing in the UK, Europe, and USA, Durbin takes a strategic, consultative approach to understand the precise needs of the pharmaceutical company, the product, the disease area, and of the HCPs and patients in question. We then draw on technology to design a 360° solution that incorporates effective global distribution, country-specific regulations, and real-world data insights.
Tanner Pharma Group is a specialist pharmaceutical services provider headquartered in Charlotte, NC USA with offices in the United Kingdom, Switzerland, Ireland and Brazil. With a focus on improving patient lives by increasing access to medicines around the world, the company has developed a portfolio of service offerings that provide international commercialization and patient access through licensing, managed access programs, global access programs and clinical trial services, as well as donation programs through biopharmaceutical and non-profit partnerships. By partnering with Tanner Pharma Group, companies are able to focus on their primary markets while ensuring that patients and clinicians receive the products they need through compliant and controlled channels. For more information, visit www.tannerpharma.com.
Smartway designs, implements, and manages global programs that empower access to innovative therapies.
We partner with pharma and biotech organizations to deliver customized programs that transform lives. These partnerships have made us a leader in the provision of Expanded Access, Early Access, Compassionate Use, and Named Patient Programs across 98 countries. Over the last 20 years, we’ve gained the experience it takes to strategically advice, design, initiate, and manage global or regional programs with you.
We provide end-to-end solutions to manage complex EAPs. Whatever your size and scale, we’re dedicated to empowering patient access to the right therapy
Bionical Emas EAP is the only specialist Early Access Program (EAP) partner to harness the full power of an established and successful Clinical Research Organization. Our global EAP experience in oncology and rare disease areas is perfectly complemented by a full range of in-house services, providing our clients a superior experience for the benefit of healthcare professionals and patients.
Our mission is to positively impact the lives of patients and their families all around the world. Our goal is to help current and future generations, providing timely and appropriate treatment access to patients in desperate need.